Sequential alterations in catabolic and anabolic gene expression parallel pathological changes during progression of

Jin Nam1, Priyangi Perera, Jie Liu

  • 1The Biomechanics and Tissue Engineering Laboratory, College of Dentistry, The Ohio State University, Columbus, Ohio, United States of America.

Plos One
|September 21, 2011
PubMed

Insights

Chronic inflammation drives osteoarthritis cartilage destruction. This study reveals distinct gene expression patterns, including inflammatory mediators and suppressed matrix synthesis genes, that correlate with osteoarthritis progression in rats.

Area of Science:

  • Biomedical Science
  • Molecular Biology
  • Immunology

Background:

  • Osteoarthritis (OA) is characterized by cartilage destruction, significantly driven by chronic inflammation.
  • Understanding the molecular mechanisms underlying OA progression is crucial for developing effective treatments.

Purpose of the Study:

  • To systematically analyze gene expression changes during the progression of cartilage destruction in a rat model of monoiodoacetate-induced arthritis (MIA).
  • To correlate these molecular changes with macroscopic, microscopic, and micro-computed tomography findings of OA progression.

Main Methods:

  • Intra-articular injection of monoiodoacetate in Sprague Dawley female rats to induce MIA.
  • Monitoring disease progression macroscopically, microscopically, and via micro-computed tomography.
  • Transcriptome-wide gene expression analysis using Affymetrix GeneChip, with validation by real-time PCR.
  • Functional network analysis using Ingenuity Pathways Analysis (IPA) to identify key molecular interactions.

Main Results:

  • Cartilage damage progressed from Grade 1 at day 5 to Grade 3-3.5 by day 21.
  • Early damage (Grade 1) showed upregulation of acute inflammatory genes and suppression of musculoskeletal development genes.
  • Moderate damage (Grade 2) involved upregulation of chronic inflammatory and immune trafficking genes.
  • Severe damage (Grade 3-3.5) was associated with chronic inflammatory and immune adaptation genes.
  • Key inflammatory mediators (IL-1β, TNF-α, NF-κB) and suppressed anabolic factors (SOX-9, TGF-β) were identified as central nodes.

Conclusions:

  • Temporal regulation of specific gene clusters, including inflammatory mediators and proteases, controls OA cartilage destruction.
  • Inflammatory networks involving IL-1β, TNF-α, and NF-κB drive catabolic processes.
  • Suppression of matrix synthesis and chondrocytic activity, mediated by factors like asporin and downregulated TGF-β, contributes to disease progression.